STATE-OF-THE-ART PAPER
New aspects in the pathogenesis of diabetic atherothrombosis
Pedro R. Moreno, MD*, ,* and
Valentin Fuster, MD, PhD*
* Zena and Michael Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York
Gill Heart Institute, University of Kentucky, Lexington, Kentucky
Manuscript received April 2, 2004;
revised manuscript received May 20, 2004,
accepted July 5, 2004.
* Reprint requests and correspondence: Dr. Pedro R. Moreno, Cardiovascular Institute, Mount Sinai School of Medicine, P.O. Box 1030, One Gustave L. Levy Place, New York, New York 10029 (Email: Pedro.Moreno{at}msnyuhealth.org).
Diabetes mellitus is increasing worldwide, resulting from the interaction of obesity, inflammation, and hyperglycemia. Activated immunity and cytokine production lead to insulin resistance and other components of the metabolic syndrome, establishing the link between diabetes and atherosclerosis. Hyperglycemia-induced endothelial dysfunction is mediated by increased oxidative stress, a promoter of adventitial inflammation and vasa vasorum neovascularization in experimental models of diabetic atherosclerosis. Recent studies have documented increased inflammation, neovascularization, and intraplaque hemorrhage in human diabetic atherosclerosis. This inflammatory microangiopathic process is independently associated with plaque rupture, leading to coronary thrombosis. Tissue factor, the most potent trigger of the coagulation cascade, is increased in diabetic patients with poor glycemic control. Circulating tissue factor microparticles are also associated with apoptosis of plaque macrophages, closing the link among inflammation, plaque rupture, and blood thrombogenicity. High-density lipoproteins, responsible for free cholesterol removal, are reduced in patients with insulin resistance and diabetes. High-density lipoprotein therapy leads to a significant decrease in plaque macrophages and increase in smooth-muscle cells. These beneficial effects may be responsible for coronary plaque stabilization in patients treated with recombinant Apolipoprotein A-I Milano/phospholipid complex. Finally, peroxisomal proliferator-activated receptors (PPARs) are now considered the nuclear transcriptional regulators of atherosclerosis. Three subfamilies, including PPAR-alpha, -delta, and -gamma, have been identified with crucial roles in lipid metabolism, plaque inflammation, expression of adhesion molecules and cytokines, and regulation of matrix metalloproteinases. Multiple experimental studies have documented plaque stabilization with PPAR-gamma agonists, a group of medications holding great promise in the treatment of diabetes atherosclerosis.
|
Abbreviations and Acronyms
| | AGE = advanced glycation end product | | HDL = high-density lipoprotein | | MMP = matrix metalloproteinase | | PPAR = peroxisomal proliferator-activated receptor | | ROS = reactive oxygen species | | TF = tissue factor |
|
This article has been cited by other articles:
|
|
|
|
 
P. R. Moreno, J. Sanz, and V. Fuster
Promoting Mechanisms of Vascular Health: Circulating Progenitor Cells, Angiogenesis, and Reverse Cholesterol Transport
J. Am. Coll. Cardiol.,
June 23, 2009;
53(25):
2315 - 2323.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Ronald, Y. Chen, A. J.-L. Belisle, A. M. Hamilton, K. A. Rogers, R. A. Hegele, B. Misselwitz, and B. K. Rutt
Comparison of Gadofluorine-M and Gd-DTPA for Noninvasive Staging of Atherosclerotic Plaque Stability Using MRI
Circ Cardiovasc Imaging,
May 1, 2009;
2(3):
226 - 234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. J. Hong, M. H. Jeong, Y. H. Choi, J. S. Ko, M. G. Lee, W. Y. Kang, S. E. Lee, S. H. Kim, K. H. Park, D. S. Sim, et al.
Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients.
J. Am. Coll. Cardiol. Img.,
March 1, 2009;
2(3):
339 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Orasanu and J. Plutzky
The pathologic continuum of diabetic vascular disease.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5 Suppl):
S35 - S42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Garg, S.-L. T. Normand, T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, M. R. Varma, Z. Zhou, and L. Mauri
Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results From the Massachusetts Data Analysis Center Registry
Circulation,
November 25, 2008;
118(22):
2277 - 2285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster and M. E. Farkouh
Acute Coronary Syndromes and Diabetes Mellitus: A Winning Ticket for Prasugrel
Circulation,
October 14, 2008;
118(16):
1607 - 1608.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Moreno, K. R. Purushothaman, M. Purushothaman, P. Muntner, N. S. Levy, V. Fuster, J. T. Fallon, P. A. Lento, A. Winterstern, and A. P. Levy
Haptoglobin Genotype Is a Major Determinant of the Amount of Iron in the Human Atherosclerotic Plaque
J. Am. Coll. Cardiol.,
September 23, 2008;
52(13):
1049 - 1051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Chesebro
Diabetic atherothrombosis: helpful adjunctive therapy
Eur. Heart J.,
September 2, 2008;
29(18):
2191 - 2192.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Sander, K. Sander, and H. Poppert
Review: Stroke in type 2 diabetes
The British Journal of Diabetes & Vascular Disease,
September 1, 2008;
8(5):
222 - 229.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. F. Lehmann and B. B. Lohray
A Lesson in Moderation: Applying Pharmacodynamics to Clarify the Relationship Between Thiazolidinediones and Adverse Vascular Outcomes in Type 2 Diabetes
J. Clin. Pharmacol.,
August 1, 2008;
48(8):
999 - 1002.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Coli, M. Magnoni, G. Sangiorgi, M. M. Marrocco-Trischitta, G. Melisurgo, A. Mauriello, L. Spagnoli, R. Chiesa, D. Cianflone, and A. Maseri
Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries correlation with histology and plaque echogenicity.
J. Am. Coll. Cardiol.,
July 15, 2008;
52(3):
223 - 230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B.-J. Shen, A. J. Countryman, A. Spiro III, and R. Niaura
The Prospective Contribution of Hostility Characteristics to High Fasting Glucose Levels: The moderating role of marital status
Diabetes Care,
July 1, 2008;
31(7):
1293 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dickinson, T. Rogers, B. Kasiske, S. Bertog, G. Tadros, J. Malik, R. Wilson, and C. Panetta
Coronary Artery Disease in Young Women and Men With Long-Standing Insulin-dependent Diabetes
Angiology,
March 1, 2008;
59(1):
9 - 15.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. A. Towler
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
IBMS BoneKEy,
February 1, 2008;
5(2):
41 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Baumgart, V. Klauss, F. Baer, F. Hartmann, H. Drexler, W. Motz, H. Klues, S. Hofmann, W. Volker, T. Pfannebecker, et al.
One-Year Results of the SCORPIUS Study: A German Multicenter Investigation on the Effectiveness of Sirolimus-Eluting Stents in Diabetic Patients
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1627 - 1634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Wang, D. L. Bhatt, K. A.A. Fox, S. R. Steinhubl, D. M. Brennan, W. Hacke, K.-H. Mak, T. A. Pearson, W. E. Boden, P. G. Steg, et al.
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial
Eur. Heart J.,
September 2, 2007;
28(18):
2200 - 2207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Levy, K. R. Purushothaman, N. S. Levy, M. Purushothaman, M. Strauss, R. Asleh, S. Marsh, O. Cohen, S. K. Moestrup, H. J. Moller, et al.
Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype: Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability
Circ. Res.,
July 6, 2007;
101(1):
106 - 110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Lorenz, P. Karbstein, H. S. Markus, and M. Sitzer
High-Sensitivity C-Reactive Protein Is Not Associated With Carotid Intima-Media Progression: The Carotid Atherosclerosis Progression Study
Stroke,
June 1, 2007;
38(6):
1774 - 1779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res.,
March 30, 2007;
100(6):
769 - 781.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Juutilainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women
Diabetes Care,
February 1, 2007;
30(2):
292 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G Noordzij, E. Boersma, F. Schreiner, M. D Kertai, H. H H Feringa, M. Dunkelgrun, J. J Bax, J. Klein, and D. Poldermans
Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery
Eur. J. Endocrinol.,
January 1, 2007;
156(1):
137 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Erdei, Z. Bagi, I. Edes, G. Kaley, and A. Koller
H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H649 - H656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Pontiroli, P. Pizzocri, R. Paroni, and F. Folli
Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) Obesity: Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding
Diabetes Care,
December 1, 2006;
29(12):
2735 - 2738.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Park, S. S. Choe, A H. Choi, K. H. Kim, M. J. Yoon, T. Suganami, Y. Ogawa, and J. B. Kim
Increase in Glucose-6-Phosphate Dehydrogenase in Adipocytes Stimulates Oxidative Stress and Inflammatory Signals
Diabetes,
November 1, 2006;
55(11):
2939 - 2949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tschoepe and B. Stratmann
Plaque stability and plaque regression: new insights
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_F):
F34 - F39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Barter
Options for therapeutic intervention: how effective are the different agents?
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_F):
F47 - F53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Chapman
How does nicotinic acid modify the lipid profile?
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_F):
F54 - F59.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Otsuka, S. Sugiyama, S. Kojima, H. Maruyoshi, T. Funahashi, K. Matsui, T. Sakamoto, M. Yoshimura, K. Kimura, S. Umemura, et al.
Plasma Adiponectin Levels Are Associated With Coronary Lesion Complexity in Men With Coronary Artery Disease
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1155 - 1162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Feinstein
Contrast Ultrasound Imaging of the Carotid Artery Vasa Vasorum and Atherosclerotic Plaque Neovascularization
J. Am. Coll. Cardiol.,
July 18, 2006;
48(2):
236 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-S. Shao, J. Cai, and D. A. Towler
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2006;
26(7):
1423 - 1430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. F. Slaughter
Hemostasis and glycemic control in the cardiac surgical patient.
Seminars in Cardiothoracic and Vascular Anesthesia,
June 1, 2006;
10(2):
176 - 179.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. R. Moreno, K-R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster
Neovascularization in Human Atherosclerosis
Circulation,
May 9, 2006;
113(18):
2245 - 2252.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sata
Role of Circulating Vascular Progenitors in Angiogenesis, Vascular Healing, and Pulmonary Hypertension: Lessons From Animal Models
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2006;
26(5):
1008 - 1014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Shimabukuro, N. Higa, I. Chinen, K. Yamakawa, and N. Takasu
Effects of a Single Administration of Acarbose on Postprandial Glucose Excursion and Endothelial Dysfunction in Type 2 Diabetic Patients: A Randomized Crossover Study
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
837 - 842.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kathiresan, P. Gona, M. G. Larson, J. A. Vita, G. F. Mitchell, G. H. Tofler, D. Levy, C. Newton-Cheh, T. J. Wang, E. J. Benjamin, et al.
Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function
Circulation,
February 21, 2006;
113(7):
938 - 945.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Cordero and E Alegria
Sex differences and cardiovascular risk
Heart,
February 1, 2006;
92(2):
145 - 146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Scholz, W. Sandberg, J. K. Damas, C. Smith, A. K. Andreassen, L. Gullestad, S. S. Froland, A. Yndestad, P. Aukrust, and B. Halvorsen
Enhanced Plasma Levels of LIGHT in Unstable Angina: Possible Pathogenic Role in Foam Cell Formation and Thrombosis
Circulation,
October 4, 2005;
112(14):
2121 - 2129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hamerman
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
QJM,
July 1, 2005;
98(7):
467 - 484.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
